Vitamin D Supplementation in Acne - Trial NCT06141330
Access comprehensive clinical trial information for NCT06141330 through Pure Global AI's free database. This phase not specified trial is sponsored by HITEC-Institute of Medical Sciences and is currently Not yet recruiting. The study focuses on Acne Vulgaris. Target enrollment is 58 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
HITEC-Institute of Medical Sciences
Timeline & Enrollment
N/A
Dec 01, 2023
Mar 01, 2024
Primary Outcome
Efficacious
Summary
The goal of this clinical trial is to compare in acne vulgaris patients. The main question it
 aims to answer is:
 
 • To assess the therapeutic benefit of vitamin D supplement in acne vulgaris treatment,
 following a 2-month treatment regimen that includes vitamin D supplementation compared to
 conventional (systemic azithromycin and topical retinoid) treatment alone.
 
 Participants will receive vitamin D supplements in addition to capsule Azithromycin and
 topical retinoid.
 
 Researchers will compare groups to determine efficacy of Vitamin D supplements in the
 treatment of Acne vulgaris.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06141330
Non-Device Trial